A Postmarketing Surveillance Program for Nutropin, Nutropin AQ, and Protropin
This study is a multicenter, open label, observational, postmarketing surveillance study of Nutropin AQ, Nutropin, and Protropin in the United States and Canada. This study (and subsequent substudies) were developed to investigate specific aspects of growth hormone (GH) treatment.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Genentech National Cooperative Growth Study (NCGS) Postmarketing Surveillance Program for Nutropin AQ [Somatropin (rDNA Origin) Injection], Nutropin [Somatropin (rDNA Origin) for Injection], and Protropin [Somatrem for Injection]|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00097539
|Study Director:||Barbara Lippe, M.D.||Genentech, Inc.|